Data from EMC - Curated by EPG Health - Last updated 12 June 2018

Indication(s)


- Pantoprazole 20 mg gastro-resistant tablets:

Adults and adolescents 12 years of age and above
Symptomatic gastro-oesophageal reflux disease.
For long-term management and prevention of relapse in reflux oesophagitis.

Adults
Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAID treatment


- Pantoprazole 40 mg gastro-resistant tablets:

Adults and adolescents 12 years of age and above
− Reflux oesophagitis

Adults
− Eradication of Helicobacter pylori (H. pylori) in combination with appropriate antibiotic therapy in patients with H. pylori associated ulcers.
− Gastric and duodenal ulcer.
− Zollinger-Ellison Syndrome and other pathological hypersecretory conditions.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Hereditary ATTR amyloidosis

Hereditary ATTR amyloidosis

Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.

Cushing's Syndrome

Cushing's Syndrome

Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?

+ 2 more

Load more

Related Content

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder Takeda GmbH